Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
- 25 March 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (12), 2101-2106
- https://doi.org/10.1038/sj.onc.1202512
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 36 references indexed in Scilit:
- First p53 Relative May Be a New Tumor SuppressorScience, 1997
- Lonely No More: p53 Finds Its Kin in a Tumor Suppressor HavenCell, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.Genes & Development, 1997
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- p53, guardian of the genomeNature, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992